Standout Papers
Immediate Impact
72 standout
Citing Papers
Pancreatic cancer: Advances and challenges
2023 Standout
NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): a randomised, open-label, phase 3 trial
2023 Standout
Works of F Marchesi being referenced
EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary
2009 Standout
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| F Marchesi | 102 | 438 | 27 | 211 | 179 | 3 | 760 | |
| Daniele Lisi | 115 | 548 | 24 | 300 | 272 | 10 | 985 | |
| Mary Doroshenk | 127 | 554 | 4 | 276 | 89 | 9 | 871 | |
| P Carli | 134 | 459 | 83 | 210 | 223 | 13 | 897 | |
| Bruce Ferguson | 66 | 464 | 43 | 260 | 114 | 6 | 891 | |
| E Silverberg | 106 | 414 | 41 | 317 | 253 | 8 | 958 | |
| Janine Bell | 117 | 412 | 22 | 112 | 180 | 11 | 979 | |
| E S Pollack | 107 | 327 | 16 | 137 | 118 | 10 | 777 | |
| Roman Shyyan | 59 | 584 | 5 | 182 | 93 | 8 | 916 | |
| C. Round | 81 | 296 | 211 | 145 | 108 | 7 | 717 | |
| 登 栗原 | 77 | 388 | 21 | 176 | 167 | 8 | 804 |
All Works
Loading papers...